• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Diabetes Center Berne launches open innovation challenge for diabetes tech

June 15, 2021 By Sean Whooley

Diabetes Center Berne DCBThe Diabetes Center Berne today announced the launch of an initiative to develop technology to address the treatment of diabetes.

DCB is seeking innovators, co-creators, scientists and members of the diabetes community to join the company’s innovation challenge and join its community of diabetes technology developers.

The center requested anyone ranging from members of start-ups, healthcare professionals, researchers or individuals, saying that, if they have an idea or insight into how to improve the lives of those living with diabetes, they should bring it to the challenge.

DCB listed the topic for the challenge as “can your idea change glucose measurement forever?”

“In the last few years, diabetes technology has made enormous progress in improving the lives of people living with diabetes,” the center wrote in a news release. “However, there is still a great unmet need for innovative technology solutions that help ease the burden of diabetes and improve the lives of people who have it. One of these unmet needs is better glucose measurement.

“People with diabetes are asking for methods of glucose measurement that are more convenient, less invasive and more affordable. Hence why Diabetes Center Berne (DCB) is setting this challenge.”

Filed Under: Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Research & Development Tagged With: Diabetes, Diabetes Center Berne

IN CASE YOU MISSED IT

  • Insulet’s Omnipod Discover data platform begins full US rollout
  • BD’s IV catheters plant in Utah marks 70 years
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact
  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • Dexcom CFO to expand into COO role

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS